The estimated Net Worth of Capital Management, Llc Aqu... is at least 20 百万$ dollars as of 22 September 2022. Capital Aqu owns over 1,901,796 units of Spero Therapeutics Inc stock worth over 4,582,043$ and over the last 4 years Capital sold SPRO stock worth over 15,413,713$.
Sign up
Capital Aqu SPRO stock SEC Form 4 insiders trading
Capital has made over 23 trades of the Spero Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Capital sold 1,901,796 units of SPRO stock worth 4,279,041$ on 22 September 2022.
The largest trade Capital's ever made was selling 1,901,796 units of Spero Therapeutics Inc stock on 22 September 2022 worth over 4,279,041$. On average, Capital trades about 176,598 units every 30 days since 2020. As of 22 September 2022 Capital still owns at least 3,419,435 units of Spero Therapeutics Inc stock.
You can see the complete history of Capital Aqu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at Spero Therapeutics Inc
Over the last 15 years, insiders at Spero Therapeutics Inc have traded over 15,920,732$ worth of Spero Therapeutics Inc stock and bought 3,223,281 units worth 44,767,755$ . The most active insiders traders include Plc Gsk、Jean Francois Formela、Capital Management, Llc Aqu.... On average, Spero Therapeutics Inc executives and independent directors trade stock every 71 days with the average trade being worth of 122,858$. The most recent stock trade was executed by Ankit Mahadevia on 27 August 2024, trading 5,912 units of SPRO stock currently worth 7,981$.
What does Spero Therapeutics Inc do?
spero therapeutics is focused on the development of novel therapies to treat highly resistant bacterial infections. the culture at spero is one of respect, action, collaboration and transparency. spero team members are leaders in the field, and have the ability and desire to be a part of a team. at spero, a feeling that we are part of something groundbreaking and innovative fuels our approach.
What does Spero Therapeutics Inc's logo look like?
Complete history of Capital Aqu stock trades at Spero Therapeutics Inc
Spero Therapeutics Inc executives and stock owners
Spero Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Ankit Mahadevia,
President, Chief Executive Officer, Director -
Dr. Ankit Mahadevia M.D., MBA,
Co-Founder, CEO, Pres & Director -
Cristina Larkin,
Chief Operating Officer and Chief Commercial Officer -
David Melnick,
Cheif Medical Officer -
Dr. David A. Melnick M.D.,
Chief Medical Officer -
Cristina Larkin,
Chief Operating Officer -
Thomas Parr,
Chief Scientific Officer -
Cynthia Smith,
Independent Director -
Milind Deshpande,
Independent Chairman of the Board -
Frank Thomas,
Independent Director -
Patrick Vink,
Independent Director -
John Pottage,
Independent Director -
Jean-Francois Formela,
Independent Director -
Sharon Klahre,
IR Contact Officer -
Scott Jackson,
Independent Director -
Timothy Keutzer,
Chief Development Officer -
Stephen DiPalma,
Chief Financial Officer, Treasurer -
Timothy Keutzer,
Chief Devel. Officer -
James P. Brady,
Chief Human Resource Officer -
David Musselman,
Sr. VP of Sales & Market Access -
Tamara Lynn Joseph L.L.M., J.D.,
Chief Legal Officer -
Ted Jenkins,
VP & Head of Investor Relations -
Dr. Thomas R. Parr Jr., Ph.D.,
Chief Scientific Officer -
Satyavrat Shukla C.F.A.,
Chief Financial Officer -
David P Southwell,
Director -
John J Gorman,
Director -
Jack Fingerhut,
President -
Allen S Greene,
Chairman of the Board and CEO -
Lager H Martin,
Director -
Joel Sendek,
Chief Financial Officer -
Plc Gsk,
10% owner -
Joseph R Fish,
EVP & Chief Technology Officer -
Leonard J Stanley,
Director -
Vikas Goyal,
Director -
Casper Breum,
Director -
Stanley P Wirtheim,
Chief Financial Officer -
Zohar Ben Dov,
10% owner -
Esther Rajavelu,
See Remarks -
Capital Management, Llc Aqu...,
-
Kathleen Tregoning,
-
Kamal Hamed,
Chief Medical Officer -
Sath Shukla,
CEO & President -
Tamara L Joseph,
Chief Legal Officer